AQR Capital Management’s Utah Medical Products UTMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $491K | Buy |
+8,620
| New | +$491K | ﹤0.01% | 2620 |
|
|
2024
Q4 | – | Sell |
-8,874
| Closed | -$594K | – | 2963 |
|
|
2024
Q3 | $594K | Buy |
8,874
+1,723
| +24% | +$115K | ﹤0.01% | 2085 |
|
|
2024
Q2 | $478K | Buy |
+7,151
| New | +$478K | ﹤0.01% | 2072 |
|
|
2022
Q3 | – | Sell |
-5,346
| Closed | -$459K | – | 2326 |
|
|
2022
Q2 | $459K | Buy |
5,346
+2,218
| +71% | +$190K | ﹤0.01% | 1711 |
|
|
2022
Q1 | $281K | Buy |
+3,128
| New | +$281K | ﹤0.01% | 1977 |
|
|
2021
Q1 | – | Sell |
-4,840
| Closed | -$408K | – | 2267 |
|
|
2020
Q4 | $408K | Sell |
4,840
-9,234
| -66% | -$778K | ﹤0.01% | 1859 |
|
|
2020
Q3 | $1.12M | Sell |
14,074
-58
| -0.4% | -$4.63K | ﹤0.01% | 1359 |
|
|
2020
Q2 | $1.25M | Sell |
14,132
-225
| -2% | -$19.9K | ﹤0.01% | 1369 |
|
|
2020
Q1 | $1.35M | Buy |
14,357
+281
| +2% | +$26.4K | ﹤0.01% | 1215 |
|
|
2019
Q4 | $1.52M | Sell |
14,076
-3,742
| -21% | -$404K | ﹤0.01% | 1373 |
|
|
2019
Q3 | $1.71M | Sell |
17,818
-220
| -1% | -$21.1K | ﹤0.01% | 1329 |
|
|
2019
Q2 | $1.73M | Sell |
18,038
-1,416
| -7% | -$135K | ﹤0.01% | 1315 |
|
|
2019
Q1 | $1.72M | Sell |
19,454
-2,617
| -12% | -$231K | ﹤0.01% | 1369 |
|
|
2018
Q4 | $1.83M | Sell |
22,071
-7,279
| -25% | -$605K | ﹤0.01% | 1281 |
|
|
2018
Q3 | $2.77M | Buy |
29,350
+27,286
| +1,322% | +$2.57M | ﹤0.01% | 1249 |
|
|
2018
Q2 | $227K | Buy |
+2,064
| New | +$227K | ﹤0.01% | 2192 |
|